Man on a mission dhakacourier.com.bd - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dhakacourier.com.bd Daily Mail and Mail on Sunday newspapers.
Karnataka defers launch of Covid vax drive for people aged 18-44 yrs
By IANS |
Published on
Fri, Apr 30 2021 15:27 IST |
16 Views
Follow the Pediatric vaccine schedule even in coronavirus. Image Source: IANS News
Bengaluru, April 30 : The Karnataka government has deferred the roll-out of the Covid-19 inoculation drive for those in the 18-44 years age group from Saturday.
State s Health Minister, K. Sudhakar told reporters that the new dates for inoculation for this age group (18-44 years) will be announced once the state receives the required quantity of dosage of vaccine to start the drive. I appeal to our people not to crowd in front of any hospital as inoculation drive won t commence from May 1 as it was decided earlier, he said.
COVID-19 Highlights: Maharashtra reports 66,159 new COVID-19 cases, 771 deaths
Mirror Online / Updated: Apr 29, 2021, 21:51 IST
COVID-19 cases and 771 fatalities, taking the tally of total cases to 45,39,553.
Mumbai has recorded 4192 cases with the death toll climbing again with 82 fatalities. The overall toll has increased to 67,985. Whereas, 68,537 patients were discharged from hospitals during the day, taking the number of recoveries to 37,99,266. The active cases in the state now stand at 6,70,301. The state s recovery rate is at 83.69 per cent, while the fatality rate was 1.5 per cent.
Mumbai: No COVID vaccination in the city till May 2 due to shortage of doses
The Brihanmumbai Municipal corporation (BMC) on Thursday said that the COVID-19 vaccination will not take place in the city for the next three days due to a shortage of doses. The civic body also informed that from now onwards, vaccine shots will be given to those who have registered.
WASHINGTON (IANS) â The made-in India Covaxin vaccine, developed by Hyderabad-based Bharat Biotech, can neutralize the B1617 variant of coronavirus, said White House s chief medical adviser Dr. Anthony Fauci. Now, this is something we are still gaining data on, but most recent data looking at convalescent sera of Covid-19 cases in people who received Covaxin, it was found to neutralize the 617 variant, Fauci was quoted as saying during the White House press briefing.
Fauci, President Joe Biden s chief adviser on the Covid pandemic, quoted the recent Phase 3 clinical trials of Covaxin by ICMR, which claimed that the vaccine neutralizes multiple variants of SARS-CoV-2 and effectively neutralizes the double mutant strain (B1617) as well. He called vaccination an important antidote.â